(Q44487840)

3 December 2017

A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study (English)

1 reference

3 December 2017

4

1 reference

3 December 2017

Christopher S R Baker

1

1 reference

3 December 2017

Andrew Wragg

2

1 reference

3 December 2017

Sanjay Kumar

3

1 reference

3 December 2017

Laurence R I Baker

5

1 reference

3 December 2017

Charles J Knight

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

3 December 2017

1 reference

3 December 2017

41

1 reference

3 December 2017

2114-2118

1 reference

3 December 2017

12

1 reference

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Hospital-acquired renal insufficiency: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Contrast-medium-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Prevention of contrast nephropathy after cardiac catheterisation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Acetylcysteine and contrast agent-associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Safety and Cost Effectiveness of High-Osmolality as Compared with Low-Osmolality Contrast Material in Patients Undergoing Cardiac Angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Comparison of iodixanol and iohexol in renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

Nephrotoxic effects in high-risk patients undergoing angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900487-X

7 January 2021

10.1016/S0735-1097(03)00487-X

Identifiers

DOI

1 reference

3 December 2017

1 reference